FDA panel OKs looser restrictions on Avandia

In a reversal of its past position, a majority of a 26-person Food and Drug Administration advisory panel voted to recommend looser restrictions on the controversial diabetes drug Avandia.

http://rss.cnn.com/~r/rss/cnn_health/~3/_U80BV8kMKg/index.html

Source: CNN.com - Health - June 6, 2013 Category: Consumer Health News Source Type: news

More News: Avandia | Diabetes | Endocrinology | Food and Drug Administration (FDA) | Health